Tech Company Financing Transactions

CytomX Therapeutics Funding Round

Canaan Partners, Roche Venture Fund and Third Rock Ventures invested in a $31 million Series B funding round for CytomX Therapeutics. The financing closed on 7/31/2012.

Transaction Overview

Announced On
Transaction Type
Venture Equity
Series B

Canaan Partners (Lead Investor) (Timothy Shannon)

Roche Venture Fund

Third Rock Ventures (Neil Exter)

Proceeds Purpose
Proceeds from the expanded Series B financing round will support the advancement of the company's lead programs toward the clinic and the execution on broad business development activities aimed at the formation of key partnerships in oncology and inflammatory disease.

Company Information

Company Status
Mailing Address
151 Oyster Point Blvd. 400
San Francisco, CA 94080
Email Address
CytomX (NASDAQ: CTMX) is unlocking the potential of antibody therapeutics in oncology by developing a novel therapeutic antibody class of highly targeted Probody therapeutics.
CytomX Therapeutics LinkedIn Company Profile
Social Media
CytomX Therapeutics Company Twitter Account
Company News
CytomX Therapeutics News
CytomX Therapeutics on Facebook
CytomX Therapeutics on YouTube

Management Team

Email & Social
Chief Executive Officer
Sean McCarthy
  Sean McCarthy LinkedIn Profile  Sean McCarthy Twitter Account  Sean McCarthy News  Sean McCarthy on Facebook
Chief Scientific Officer
Michael Kavanaugh
  Michael Kavanaugh LinkedIn Profile  Michael Kavanaugh Twitter Account  Michael Kavanaugh News  Michael Kavanaugh on Facebook
Vice President
Alison Joly
  Alison Joly LinkedIn Profile  Alison Joly Twitter Account  Alison Joly News  Alison Joly on Facebook
VP - Human Resources
Danielle Olander
  Danielle Olander LinkedIn Profile  Danielle Olander Twitter Account  Danielle Olander News  Danielle Olander on Facebook
VP - Manufacturing
Sridhar Viswanathan
  Sridhar Viswanathan LinkedIn Profile  Sridhar Viswanathan Twitter Account  Sridhar Viswanathan News  Sridhar Viswanathan on Facebook



Browse more venture capital transactions:

Prev: 7/31/2012: TrueVision Systems venture capital transaction
Next: 7/31/2012: 9GAG venture capital transaction


Share this article


About Our VC Transactions Data

We do our best to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary